. The company’s pipeline contains 4 clinical-stage therapies. Its most Highly developed drug applicant is ROS1 inhibitor taletrectinib for managing lung cancer. Nuvation is finishing two phase two pivotal research on taletrectinib.On April eleven, after publishing various tweets vital with the company, Musk announced he experienced made the decis